KLOW vs GLOW Peptide Blends: What’s the Difference?
Ask five researchers what separates the KLOW and GLOW peptide blends and you'll get five slightly different answers. That's a problem, ...
Best Peptides for Weight Loss in 2026: A Mechanistic Guide
A mechanistic ranking of weight-loss peptides studied in 2026: GLP-1s, GLP-1/GIP, triple agonists, AOD-9604, 5-Amino-1-MQ, and tesamorelin.
5-Amino-1-MQ: NNMT Inhibitor and Metabolic Pathway Guide
5-Amino-1-MQ is a small-molecule NNMT inhibitor studied for its effects on adipocyte energy balance, SAM availability, and metabolic rate.
Tesamorelin Guide: GHRH Analog and Visceral Fat Biology
Tesamorelin is a stabilized GHRH analog studied for its effect on visceral adipose tissue via pulsatile GH release. A mechanistic breakdown.
Retatrutide Explained: Triple Agonist Peptide (GLP-1/GIP/Glucagon) Science
Retatrutide is a first-in-class triple agonist targeting GLP-1, GIP, and glucagon receptors. A mechanistic guide to this next-generation metabolic peptide.
AOD-9604 Research Guide: GH Fragment, Lipolysis Mechanisms, and Metabolic Research
A comprehensive research guide to AOD-9604 — the C-terminal fragment of human growth hormone studied for fat-specific lipolytic activity, adipocyte biology, and metabolic research applications.
Semaglutide vs Tirzepatide: A Researcher’s Comparison of GLP-1 and Dual-Incretin Agonists
A research-focused comparison of semaglutide (GLP-1 agonist) and tirzepatide (GIP/GLP-1 dual agonist): mechanisms of action, structural differences, key clinical trial data, and considerations for metabolic research design.